This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/518796-astrazeneca-europe-britain-vaccine-poll/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| EU citizens losing faith in AstraZeneca vaccine, poll shows, but new trial data reveal jab more effective than originally thought | EU citizens losing faith in AstraZeneca vaccine, poll shows, but new trial data reveal jab more effective than originally thought |
| (6 months later) | |
| AstraZeneca is trying to salvage its safety profile by publishing new positive data from a recent US trial of its vaccine. Still, trust in the jab is falling across the EU, a YouGov poll has shown. | AstraZeneca is trying to salvage its safety profile by publishing new positive data from a recent US trial of its vaccine. Still, trust in the jab is falling across the EU, a YouGov poll has shown. |
| On Monday, the embattled pharmaceutical giant AstraZeneca published positive results from its US trial, which showed the jab to have 79% efficacy in preventing symptomatic Covid-19 and to be 100% effective at preventing severe disease and hospitalization. | On Monday, the embattled pharmaceutical giant AstraZeneca published positive results from its US trial, which showed the jab to have 79% efficacy in preventing symptomatic Covid-19 and to be 100% effective at preventing severe disease and hospitalization. |
| The study, which involved over 32,000 participants, found no increased risk of thrombotic events, including cerebral venous sinus thrombosis (CVST), following concerns that the jab had caused blood clots in some very rare cases. | The study, which involved over 32,000 participants, found no increased risk of thrombotic events, including cerebral venous sinus thrombosis (CVST), following concerns that the jab had caused blood clots in some very rare cases. |
| Data released in November suggested the jab was only 70.4% effective but questions were raised about the thoroughness of the trial on older generations. | Data released in November suggested the jab was only 70.4% effective but questions were raised about the thoroughness of the trial on older generations. |
| However, public perception of the jab across Europe has already been hit hard after many nations elected to temporarily suspend the vaccine’s administration while reports of blood clots were investigated by the European Medicines Agency (EMA). Last Thursday, the EMA reaffirmed the jab’s positive safety profile but the damage to AstraZeneca’s public perception had already been done. | However, public perception of the jab across Europe has already been hit hard after many nations elected to temporarily suspend the vaccine’s administration while reports of blood clots were investigated by the European Medicines Agency (EMA). Last Thursday, the EMA reaffirmed the jab’s positive safety profile but the damage to AstraZeneca’s public perception had already been done. |
| A poll released on Monday by YouGov confirmed the growing skepticism of Europeans. Earlier surveys showed that people were already more wary of the Anglo-Swedish vaccine following a series of comments by European leaders. | A poll released on Monday by YouGov confirmed the growing skepticism of Europeans. Earlier surveys showed that people were already more wary of the Anglo-Swedish vaccine following a series of comments by European leaders. |
| New data show that only 23% of French people and 32% of Germans consider the vaccine to be safe. The survey also showed that people in Italy and Spain have lost confidence in AstraZeneca. When asked in February, 59% of Spanish pollsters qualified the jab as safe. In Monday's poll, only 38% gave that answer. A similar picture is observed among Italian pollsters. | New data show that only 23% of French people and 32% of Germans consider the vaccine to be safe. The survey also showed that people in Italy and Spain have lost confidence in AstraZeneca. When asked in February, 59% of Spanish pollsters qualified the jab as safe. In Monday's poll, only 38% gave that answer. A similar picture is observed among Italian pollsters. |
| Meanwhile, there has only been a mild drop in confidence among Britons where the vaccine has been widely used and people display much more faith in all the vaccines available. The Pfizer and AstraZeneca jabs remain on par regarding public confidence. | Meanwhile, there has only been a mild drop in confidence among Britons where the vaccine has been widely used and people display much more faith in all the vaccines available. The Pfizer and AstraZeneca jabs remain on par regarding public confidence. |
| The poll shows that Swedes are trusting of AstraZeneca as well, while Danes are tied when answering about the vaccine’s safety. | The poll shows that Swedes are trusting of AstraZeneca as well, while Danes are tied when answering about the vaccine’s safety. |
| Monday’s revelations come as the EU threatens to stop exports of EU-made vaccines to the UK, amid the company’s delivery problems. A number of commentators, including prominent Brexiteer Nigel Farage questioned why the UK would send AstraZeneca jabs to Europe “when their own populations won't even take it.” | Monday’s revelations come as the EU threatens to stop exports of EU-made vaccines to the UK, amid the company’s delivery problems. A number of commentators, including prominent Brexiteer Nigel Farage questioned why the UK would send AstraZeneca jabs to Europe “when their own populations won't even take it.” |
| If you like this story, share it with a friend! | If you like this story, share it with a friend! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |